Injectable semaglutide offers the broadest range of benefits, with FDA approval for weight loss, type 2 diabetes management, and heart health protection
This slowed movement of food from the stomach into the small intestine is particularly significant for dietary tolerance, though this effect may diminish somewhat with continued use
Novo Nordisk the drugmaker of Ozempic has advised that two months before a planned pregnancy women should stop using the weight loss jab
Alcohol also increases stomach acid production, which can heighten gastrointestinal side effects like acid reflux, indigestion, nausea, and vomiting by increasing stomach acid production
Semaglutide did not increase or reduce the risk of eye disorders (odds ratio [OR], 1.01